{
    "nct_id": "NCT05399654",
    "official_title": "A Phase 1/2, Open Label, Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors",
    "inclusion_criteria": "1. Histologically or cytologically-documented solid tumors.\n2. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1.\n3. Demonstrate adequate organ function.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Prior history of or active malignant disease other than that being treated in this study.\n2. Known brain metastases or cranial epidural disease.\n3. A known hypersensitivity to the components of the study therapy or its' analogs.",
    "miscellaneous_criteria": ""
}